Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biochemical and Docking Evidence of Neurotransmitter Dysregulation in Specific Learning Disorder

NCT07240142 is registered in ClinicalTrials.gov with Dilara Ulger Ozbek as lead sponsor.

NCT NCT07240142
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07240142 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biochemical and Docking Evidence of Neurotransmitter Dysregulation in Specific Learning Disorder
Lead sponsor
Dilara Ulger Ozbek
Phase
Not applicable
Overall status
Completed
Start date
October 22, 2019
Completion date
April 16, 2021
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy (controls), specific learning disability